http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2408890-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5909722926653a7001b3ce4a1c3fc68c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c13f7c804160675976b8ccdb44f8ccd3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_171290c40591a053500a04a391532f2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e747c26758b939672efea96c720e4eb |
| publicationDate | 2011-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2408890-C1 |
| titleOfInvention | Method for prediction of myopia transition to progressive form |
| abstract | FIELD: medicine. ^ SUBSTANCE: method to forecast progressing of shortsightedness acquired during school years in children of 10-14 and 15-17 years of age. Content of carboxypropeptideprocollagen of type I is identified in blood serum with the help of immunoferment analysis. If its content is within 316/8-456 ng/ml in children of 10-14 years and 388.8-579.6 ng/ml in children of 15-17 years of age, stationary treatment of shortsightedness is forecasted. If its content is within 458.4/8-456 ng/ml in children of 10-14 years and 285.6-309.6 ng/ml in children of 15-17 years of age, progressing course of shortsightedness is forecasted. ^ EFFECT: improved accuracy of forecasting of disease course. ^ 4 ex |
| priorityDate | 2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.